Immunosyn Corp.

Immunosyn Corp.

Immunosyn Corp.

Overview
Date Founded

2006

Headquarters

10815 Rancho Bernardo Road,Suite 100,San Diego, CA 92127

Type of Company

Private

Employees (Worldwide)

2

Industries

Biotechnology

Company Description

Immunosyn Corp. is a development stage company. It engages in the marketing, distribution, and sale of a biopharmaceutical drug product SF-1019, which is used for the treatment of various diseases and pathological conditions, including chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers. The company was founded in August 2006 and is headquartered in San Diego, CA.

Executives & Employees

President & Chief Executive Officer

Chairman of the Board, Chief Financial Officer, Chief Accounting Officer & Secretary

Board of Directors

President & Founder at Argyll Biotechnologies LLC

President & Chief Executive Officer at Immunosyn Corp.

Paths to Immunosyn Corp.
Potential Connections via
Relationship Science
You
Immunosyn Corp.
Key Stats and Financials As of
Market Capitalization
$268K
Total Enterprise Value
Earnings Per Share
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Immunosyn Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Immunosyn Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Immunosyn Corp..